Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 38 studies | 38% ± 13% | |
conventional dendritic cell | 27 studies | 41% ± 10% | |
classical monocyte | 25 studies | 57% ± 12% | |
non-classical monocyte | 24 studies | 63% ± 14% | |
monocyte | 23 studies | 46% ± 14% | |
dendritic cell | 15 studies | 40% ± 16% | |
myeloid cell | 14 studies | 37% ± 14% | |
neutrophil | 10 studies | 36% ± 8% | |
microglial cell | 9 studies | 38% ± 16% | |
alveolar macrophage | 8 studies | 35% ± 11% | |
mononuclear phagocyte | 7 studies | 44% ± 17% | |
leukocyte | 6 studies | 26% ± 8% | |
intermediate monocyte | 5 studies | 62% ± 16% | |
monocyte-derived dendritic cell | 3 studies | 46% ± 20% | |
tissue-resident macrophage | 3 studies | 44% ± 12% | |
inflammatory macrophage | 3 studies | 41% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3920.65 | 576 / 578 | 91% | 19.76 | 1055 / 1155 |
breast | 82% | 492.98 | 377 / 459 | 85% | 11.55 | 949 / 1118 |
bladder | 86% | 454.24 | 18 / 21 | 64% | 8.87 | 325 / 504 |
esophagus | 70% | 476.94 | 1007 / 1445 | 79% | 11.56 | 144 / 183 |
intestine | 91% | 641.62 | 882 / 966 | 51% | 4.07 | 270 / 527 |
uterus | 66% | 302.29 | 112 / 170 | 64% | 13.65 | 296 / 459 |
thymus | 59% | 285.14 | 385 / 653 | 65% | 5.33 | 391 / 605 |
kidney | 48% | 314.28 | 43 / 89 | 74% | 9.12 | 669 / 901 |
stomach | 54% | 271.16 | 195 / 359 | 60% | 5.21 | 172 / 286 |
pancreas | 31% | 153.23 | 101 / 328 | 83% | 9.13 | 148 / 178 |
ovary | 48% | 237.10 | 87 / 180 | 66% | 5.59 | 282 / 430 |
adrenal gland | 91% | 683.84 | 235 / 258 | 18% | 0.85 | 42 / 230 |
brain | 39% | 246.97 | 1020 / 2642 | 69% | 7.12 | 484 / 705 |
skin | 51% | 243.99 | 914 / 1809 | 55% | 5.10 | 259 / 472 |
prostate | 73% | 392.76 | 180 / 245 | 29% | 1.48 | 148 / 502 |
spleen | 100% | 4329.11 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 92% | 1062.26 | 1113 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 20.97 | 39 / 45 |
blood vessel | 82% | 705.40 | 1093 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 5721.20 | 754 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 13.93 | 23 / 29 |
liver | 44% | 196.62 | 100 / 226 | 23% | 1.42 | 94 / 406 |
heart | 56% | 329.71 | 486 / 861 | 0% | 0 | 0 / 0 |
muscle | 6% | 19.50 | 51 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.31 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051712 | Biological process | positive regulation of killing of cells of another organism |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0009756 | Biological process | carbohydrate mediated signaling |
GO_0061760 | Biological process | antifungal innate immune response |
GO_1903431 | Biological process | positive regulation of cell maturation |
GO_0006954 | Biological process | inflammatory response |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0042832 | Biological process | defense response to protozoan |
GO_0032747 | Biological process | positive regulation of interleukin-23 production |
GO_2000318 | Biological process | positive regulation of T-helper 17 type immune response |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0002223 | Biological process | stimulatory C-type lectin receptor signaling pathway |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0002732 | Biological process | positive regulation of dendritic cell cytokine production |
GO_0051251 | Biological process | positive regulation of lymphocyte activation |
GO_0001775 | Biological process | cell activation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0006910 | Biological process | phagocytosis, recognition |
GO_0016046 | Biological process | detection of fungus |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0008037 | Biological process | cell recognition |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0071639 | Biological process | positive regulation of monocyte chemotactic protein-1 production |
GO_0001878 | Biological process | response to yeast |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0032930 | Biological process | positive regulation of superoxide anion generation |
GO_0071226 | Biological process | cellular response to molecule of fungal origin |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0060267 | Biological process | positive regulation of respiratory burst |
GO_0001879 | Biological process | detection of yeast |
GO_0042110 | Biological process | T cell activation |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0070884 | Biological process | regulation of calcineurin-NFAT signaling cascade |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0032491 | Biological process | detection of molecule of fungal origin |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005737 | Cellular component | cytoplasm |
GO_0038187 | Molecular function | pattern recognition receptor activity |
GO_0001872 | Molecular function | (1->3)-beta-D-glucan binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0042287 | Molecular function | MHC protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CLEC7A |
Protein name | C-type lectin domain family 7 member A isoform 1 C-type lectin domain containing 7A (C-type lectin domain family 7 member A isoform 2) (cDNA FLJ59887, moderately similar to Homo sapiens C-type lectin domain family 7, member A (CLEC7A), transcript variant 4, mRNA) C-type lectin domain containing 7A transcript variant 8 C-type lectin domain family 7 member A (Beta-glucan receptor) (C-type lectin superfamily member 12) (Dendritic cell-associated C-type lectin 1) (DC-associated C-type lectin 1) (Dectin-1) (CD antigen CD369) C-type lectin domain containing 7A transcript variant 7 |
Synonyms | CLECSF12 DKFZp686L24211 BGR UNQ539/PRO1082 DECTIN1 |
Description | FUNCTION: Lectin that functions as a pattern recognizing receptor (PRR) specific for beta-1,3-linked and beta-1,6-linked glucans, which constitute cell wall constituents from pathogenic bacteria and fungi . Necessary for the TLR2-mediated inflammatory response and activation of NF-kappa-B: upon beta-glucan binding, recruits SYK via its ITAM motif and promotes a signaling cascade that activates some CARD domain-BCL10-MALT1 (CBM) signalosomes, leading to the activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (By similarity). Enhances cytokine production in macrophages and dendritic cells (By similarity). Mediates production of reactive oxygen species in the cell (By similarity). Mediates phagocytosis of C.albicans conidia . Binds T-cells in a way that does not involve their surface glycans and plays a role in T-cell activation. Stimulates T-cell proliferation. Induces phosphorylation of SCIMP after binding beta-glucans (By similarity). . |
Accessions | A0A2Z5YRT6 Q9BXN2 ENST00000529761.5 [Q9BXN2-1] A0A2Z5YRU4 ENST00000310002.4 [Q9BXN2-9] ENST00000304084.13 [Q9BXN2-1] ENST00000531192.5 [Q9BXN2-4] ENST00000465100.5 [Q9BXN2-10] ENST00000525605.1 ENST00000349926.9 [Q9BXN2-8] Q68D78 ENST00000533022.5 [Q9BXN2-3] ENST00000396484.6 [Q9BXN2-5] ENST00000353231.9 [Q9BXN2-2] A0A0S2Z5Q1 ENST00000298523.9 [Q9BXN2-7] |